Clinical validation of whole-genome and transcriptome sequencing for genetic diagnostics in adult and pediatric AML
In the authors' words
Diagnosis and risk stratification of acute myeloid leukemia (AML) rely on the detection of diverse genetic aberrations using multiple standard-of-care (SoC) assays. With the increasing number of clinically relevant alterations and limited resolution of SoC methods, whole-genome and transcriptome sequencing (WGTS) represents a promising alternative. In this multi-center study, we evaluated the technical feasibility and clinical performance of WGTS across five sites in Sweden by comparison with SoC diagnostics. A total of 235 patients (197 adults and 38 children) underwent parallel SoC testing and WGTS analysis. WGTS identified 57/58 (98%) clinically relevant gene rearrangements detected by SoC and revealed an additional 12 rearrangements, including RUNX1::RUNX1T1, KMT2A and NUP98 rearrangements. For structural variants and copy-number variants, WGS showed 90% concordance with SoC, with discrepancies mainly involving subclonal events or tetraploidy. For gene mutations, WGS achieved 94% sensitivity, detecting all NPM1, CEBPA bZIP, and IDH1/2 mutations, but missing low-frequency FLT3-ITDs. Tumor-only analysis performed comparably to paired analysis for clinically relevant variants. Diagnostic classification was highly concordant between WGTS and SoC (WHO: 94%; ICC: 93%), with improved genetic subclassification in 5 - 6% of cases by WGTS. ELN risk stratification was concordant in 97% with WGTS reclassifying 2% of patients. Finally, a ring trial involving seven cases demonstrated complete agreement across sites in identifying aberrations. In conclusion, WGTS is a feasible and accurate comprehensive diagnostic approach for AML in a decentralized setting, improving detection of clinically relevant aberrations. However, complementary high-sensitivity assays for FLT3-ITD remain necessary for routine clinical implementation.
Appeared: Thursday, November 19. medRxiv. Preprint, not yet peer-reviewed.